diethyl 2-palmitamidomalonate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: diethyl 2-palmitamidomalonate
• 英文别名: Diethyl 2-(hexadecanoylamino)propanedioate
• 化学式: C₂₃H₄₃NO₅
• 分子量: 413.598
• InChiKey: LGVFKHCDELIZLH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  29
• 可旋转键数：
  21
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  81.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  diethyl 2-palmitamidomalonate 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 12.0h， 以29%的产率得到2-(hexadecylamino)propane-1,3-diol
  参考文献：
  名称：

  Synthesis of new ligands for targeting the S1P1 receptor

  摘要：

  Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P(1-5)). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P(1) receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [F-18]-labelling. The radioligands shall enable the imaging of S1P(1) receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.014
• 作为产物：
  描述：

  氨基丙二酸二乙酯盐酸盐 、 棕榈酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 12.25h， 以89%的产率得到diethyl 2-palmitamidomalonate
  参考文献：
  名称：

  Synthesis of new ligands for targeting the S1P1 receptor

  摘要：

  Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P(1-5)). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P(1) receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [F-18]-labelling. The radioligands shall enable the imaging of S1P(1) receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.01.014

文献信息

• Loupy, Andre; Petit, Alain; Zaparucha, Anne, Bulletin de la Societe Chimique de France, 1994, vol. 131, # 6, p. 642 - 647
  作者：Loupy, Andre、Petit, Alain、Zaparucha, Anne、Mahieu, Claude、Semeria, Didier

  DOI：——

  日期：——
• Synthesis of new ligands for targeting the S1P1 receptor
  作者：Stefanie S. Schilson、Petra Keul、Rizwan S. Shaikh、Michael Schäfers、Bodo Levkau、Günter Haufe

  DOI：10.1016/j.bmc.2015.01.014

  日期：2015.3

  Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P(1-5)). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P(1) receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [F-18]-labelling. The radioligands shall enable the imaging of S1P(1) receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases. (C) 2015 Elsevier Ltd. All rights reserved.